ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Refresh
bearishCelltrion Inc
02 Apr 2020 03:56

Celltrion Block Deals: Weirdest One to Date

Let's first recap on how the bankers structured these block deals. The discount is quite generous: 8~9.8% for Celltrion and 7~8.8% for Healthcare....

Logo
363 Views
Share
bullishCelltrion Inc
01 Apr 2020 20:13

Block Deal Sales of Celltrion & Celltrion Healthcare Stakes by ION Investments

It was reported after the market close today that GIC's investment affiliate ION Investments has put up its shares in Celltrion Inc (068270 KS) and...

Logo
410 Views
Share
bearishCelltrion Inc
01 Apr 2020 17:32

Celltrion+Celltrion Healthcare Placement- Discount Looks Enticing but the Deal Appears Opportunistic

Temasek plans to raise US$380m via selling 1.9% stake in Celltrion Healthcare (091990 KS) and another US$132m via selling a 1.5% stake in Celltrion...

Logo
365 Views
Share
31 Mar 2020 13:10

Celltrion Merger: Potential Controversy from Healthcare's Inventory Situation

Celltrion held the annual general meeting on March 27. During this meeting, CEO Seo reaffirmed the merger between the three siblings. He...

Logo
347 Views
Share
29 Mar 2020 10:02

Short Sell Ban in Korea: Targeting Block Deal Sell Swap Traders?

Korea's short-selling ban began on March 16. It will be in place for six months until September 15. Of course, market makers and program trading...

Logo
284 Views
Share
x